{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:14:48Z","timestamp":1794442488698,"version":"4.9.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1146249-1-75632"],"award-info":[{"award-number":["1146249-1-75632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI130182"],"award-info":[{"award-number":["AI130182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["L6 MD0010106"],"award-info":[{"award-number":["L6 MD0010106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009741","name":"National Blood Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010956","name":"State University of New York Upstate Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006329","name":"National Blood Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.isci.2021.102842","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T01:09:51Z","timestamp":1626224991000},"page":"102842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Targeting ITK signaling for T\u00a0cell-mediated diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Samuel","family":"Weeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2021.102842_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000000309","article-title":"Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets","volume":"38","author":"Agostinelli","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.isci.2021.102842_bib2","doi-asserted-by":"crossref","first-page":"e0215765","DOI":"10.1371\/journal.pone.0215765","article-title":"Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma","volume":"14","author":"Allchin","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2021.102842_bib3","doi-asserted-by":"crossref","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","article-title":"T-cell signaling regulated by the Tec family kinase, Itk","volume":"2","author":"Andreotti","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.isci.2021.102842_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fmicb.2014.00232","article-title":"The activity of Nef on HIV-1 infectivity","volume":"5","author":"Basmaciogullari","year":"2014","journal-title":"Front Microbiol."},{"key":"10.1016\/j.isci.2021.102842_bib5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1398-9995.2009.01991.x","article-title":"A haplotype in the inducible T-cell tyrosine kinase is a risk factor for seasonal allergic rhinitis","volume":"64","author":"Benson","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.isci.2021.102842_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.immunol.22.012703.104743","article-title":"Tec family kinases\u00a0in T lymphocyte development and\u00a0function","volume":"23","author":"Berg","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21(st) century","volume":"6","author":"Black","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.isci.2021.102842_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.40070","article-title":"Secukinumab in active rheumatoid arthritis: a phase III randomized, double-blind, active comparator- and placebo-controlled study","volume":"69","author":"Blanco","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2021.102842_bib8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.isci.2021.102842_bib9","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1074\/jbc.275.3.2219","article-title":"Biochemical interactions integrating Itk with the T\u00a0cell receptor-initiated signaling cascade","volume":"275","author":"Bunnell","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2021.102842_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.isci.2021.102842_bib11","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T\u00a0cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.isci.2021.102842_bib12","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3389\/fimmu.2018.03041","article-title":"Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease","volume":"9","author":"Chang","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4049\/immunohorizons.1900093","article-title":"CD8(+) T\u00a0cells require ITK-mediated TCR signaling for migration to the intestine","volume":"4","author":"Cho","year":"2020","journal-title":"Immunohorizons"},{"key":"10.1016\/j.isci.2021.102842_bib14","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.1501828","article-title":"A small molecule inhibitor of ITK and RLK impairs Th1 differentiation and prevents colitis disease progression","volume":"195","author":"Cho","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.41275","article-title":"Fenebrutinib versus placebo or adalimumab in rheumatoid arthritis: a randomized, double-blind, phase II trial (ANDES study)","volume":"72","author":"Cohen","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2021.102842_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.blre.2018.11.001","article-title":"Allogeneic hematopoietic cell transplantation; the current renaissance","volume":"34","author":"Copelan","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.isci.2021.102842_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/art.40737","article-title":"Adoptive treg cell therapy in a patient with systemic lupus erythematosus","volume":"71","author":"Dall'Era","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2021.102842_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib19","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.isci.2021.102842_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10875-019-00632-5","article-title":"Genetic deficiency and biochemical inhibition of ITK affect human Th17, Treg, and innate lymphoid cells","volume":"39","author":"Eken","year":"2019","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BST20190486","article-title":"Tuning T helper cell differentiation by ITK","volume":"48","author":"Elmore","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.isci.2021.102842_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ijc.33212","article-title":"Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients","volume":"148","author":"Fan","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2021.102842_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1099\/vir.0.041228-0","article-title":"Role of Itk signalling in the interaction between influenza A virus and T-cells","volume":"93","author":"Fan","year":"2012","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.isci.2021.102842_bib24","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.157.9.3769","article-title":"Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity","volume":"157","author":"Fang","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22010134","article-title":"Therapeutic potential of targeting the Th17\/Treg axis in autoimmune disorders","volume":"22","author":"Fasching","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2021.102842_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2776(06)93004-1","article-title":"Tec kinases in T\u00a0cell and mast cell signaling","volume":"93","author":"Felices","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaci.2005.12.1330","article-title":"Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase","volume":"117","author":"Ferrara","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib28","doi-asserted-by":"crossref","first-page":"25784","DOI":"10.1073\/pnas.1910701116","article-title":"Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation","volume":"116","author":"Fisher","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2021.102842_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1074-7613(00)80115-6","article-title":"Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T\u00a0cells","volume":"11","author":"Fowell","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2021.102842_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jid.2017.10.029","article-title":"ITK and RLK inhibitor PRN694 improves skin disease in two mouse models of psoriasis","volume":"138","author":"Fuhriman","year":"2018","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.isci.2021.102842_bib31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10875-014-0110-8","article-title":"Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects","volume":"34","author":"Ghosh","year":"2014","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib32","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1038\/ncomms10857","article-title":"Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4","volume":"7","author":"Gomez-Rodriguez","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2021.102842_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2009.07.009","article-title":"Differential expression of interleukin-17A and -17F is coupled to T\u00a0cell receptor signaling via inducible T\u00a0cell kinase","volume":"31","author":"Gomez-Rodriguez","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2021.102842_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.20131459","article-title":"Itk-mediated integration of T\u00a0cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T\u00a0cells","volume":"211","author":"Gomez-Rodriguez","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2021.102842_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2005.05.004","article-title":"Association of atopy and eczema with polymorphisms in T-cell immunoglobulin domain and mucin domain-IL-2-inducible T-cell kinase gene cluster in chromosome 5 q 33","volume":"116","author":"Graves","year":"2005","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib36","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1038\/s41598-018-21344-7","article-title":"IL-2 inducible kinase ITK is critical for HIV-1 infection of Jurkat T-cells","volume":"8","author":"Hain","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2021.102842_bib37","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.4049\/jimmunol.1800583","article-title":"Efficacy and pharmacodynamic modeling of the BTK inhibitor evobrutinib in autoimmune disease models","volume":"202","author":"Haselmayer","year":"2019","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib38","first-page":"1287","article-title":"Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study","volume":"263","author":"Havrdov\u00e1","year":"2016","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.isci.2021.102842_bib39","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1158\/1078-0432.CCR-20-0472","article-title":"Intratumoral IL12 mRNA therapy promotes TH1 transformation of the tumor microenvironment","volume":"26","author":"Hewitt","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2021.102842_bib40","first-page":"5762","article-title":"ITK inhibition promotes long-term survival of cardiac allografts by regulating T\u00a0cell PLC\u03b3 phosphorylation","volume":"12","author":"Huang","year":"2020","journal-title":"Am. J. Transl Res."},{"key":"10.1016\/j.isci.2021.102842_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","article-title":"Mechanism of cellular rejection in transplantation","volume":"25","author":"Ingulli","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.isci.2021.102842_bib42","series-title":"Harrison's Principles of Internal Medicine","author":"Jameson","year":"2018"},{"key":"10.1016\/j.isci.2021.102842_bib43","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.4049\/jimmunol.176.4.2430","article-title":"Functional hierarchy of the N-terminal tyrosines of SLP-76","volume":"176","author":"Jordan","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1523\/JNEUROSCI.1957-14.2015","article-title":"Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking","volume":"35","author":"Kannan","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.isci.2021.102842_bib45","doi-asserted-by":"crossref","first-page":"45935","DOI":"10.1038\/srep45935","article-title":"T-Bet independent development of IFN\u03b3 secreting natural T helper 1 cell population in the absence of Itk","volume":"7","author":"Kannan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2021.102842_bib46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg cell differentiation and function by the interleukin-21-mechanistic target of rapamycin axis via suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2021.102842_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.isci.2021.102842_bib48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.isci.2021.102842_bib49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/bloodadvances.2017011916","article-title":"Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma","volume":"2","author":"Kumar","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2021.102842_bib50","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00109-020-01958-z","article-title":"Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis","volume":"98","author":"Lechner","year":"2020","journal-title":"J.\u00a0Mol. Med. (Berl)"},{"key":"10.1016\/j.isci.2021.102842_bib51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2021.102842_bib52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-1809.2010.00637.x","article-title":"The association of a single-nucleotide polymorphism of the IL-2 inducible T-cell Kinase gene with asthma","volume":"75","author":"Lee","year":"2011","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.isci.2021.102842_bib53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdermsci.2020.01.013","article-title":"The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway","volume":"97","author":"Li","year":"2020","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.isci.2021.102842_bib54","first-page":"6097","article-title":"Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene","volume":"7","author":"Liang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.isci.2021.102842_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/1074-7613(95)90065-9","article-title":"Altered T\u00a0cell receptor signaling and disrupted T\u00a0cell development in mice lacking Itk","volume":"3","author":"Liao","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2021.102842_bib56","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1021\/bi049428r","article-title":"Selective Itk inhibitors block T-cell activation and murine lung inflammation","volume":"43","author":"Lin","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2021.102842_bib57","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.187.10.1721","article-title":"T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T\u00a0cells","volume":"187","author":"Liu","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2021.102842_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12935-019-0754-9","article-title":"ITK inhibition induced in\u00a0vitro and in\u00a0vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T\u00a0cell lymphoma","volume":"19","author":"Liu","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.isci.2021.102842_bib59","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1172\/JCI89756","article-title":"Ibrutinib treatment improves T\u00a0cell number and function in CLL patients","volume":"127","author":"Long","year":"2017","journal-title":"J.\u00a0Clin. Invest"},{"issue":"Suppl 2","key":"10.1016\/j.isci.2021.102842_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0001-7310(09)73372-1","article-title":"Progress in understanding the immunopathogenesis of psoriasis","volume":"100","author":"Mak","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.isci.2021.102842_bib61","doi-asserted-by":"crossref","first-page":"593863","DOI":"10.3389\/fimmu.2020.593863","article-title":"Targeting interleukin-2-inducible T-cell kinase (ITK) differentiates GVL and GVHD in allo-HSCT","volume":"11","author":"Mammadli","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib62","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.isci.2021.102286","article-title":"Targeting SLP76: ITK interaction separates GVHD from GVL in allo-HSCT","volume":"24","author":"Mammadli","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2021.102842_bib63","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.isci.2021.102286","article-title":"Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT","volume":"24","author":"Mammadli","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2021.102842_bib64","doi-asserted-by":"crossref","first-page":"e0215963","DOI":"10.1371\/journal.pone.0215963","article-title":"A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation","volume":"14","author":"Mamontov","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2021.102842_bib65","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I clinical trial with ex\u00a0vivo expanded recipient regulatory T\u00a0cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2021.102842_bib66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000067589","article-title":"Identification of highly expressed genes in peripheral blood T\u00a0cells from patients with atopic dermatitis","volume":"129","author":"Matsumoto","year":"2002","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2004.06.009","article-title":"Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet","volume":"21","author":"Miller","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2021.102842_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.isci.2021.102842_bib69","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","article-title":"How I treat the peripheral T-cell lymphomas","volume":"123","author":"Moskowitz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.isci.2021.102842_bib70","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.170.10.5056","article-title":"Attenuation of immunological symptoms of allergic asthma in mice lacking the tyrosine kinase ITK","volume":"170","author":"Mueller","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib71","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2020.09.023","article-title":"Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice","volume":"179","author":"Nadeem","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.isci.2021.102842_bib72","doi-asserted-by":"crossref","first-page":"104441","DOI":"10.1016\/j.phrs.2019.104441","volume":"148","author":"Nadeem","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2021.102842_bib73","doi-asserted-by":"crossref","first-page":"106369","DOI":"10.1016\/j.intimp.2020.106369","article-title":"Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17\/Treg immune responses and reduction of oxidative stress","volume":"83","author":"Nadeem","year":"2020","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.isci.2021.102842_bib74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1248\/bpb.b20-00850","article-title":"Topical application of BMS-509744, a selective inhibitor of interleukin-2-inducible T\u00a0cell kinase, ameliorates imiquimod-induced skin inflammation in mice","volume":"44","author":"Otake","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.isci.2021.102842_bib75","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2021.102842_bib76","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T\u00a0cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T\u00a0cell lymphoma","volume":"207","author":"Pechloff","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2021.102842_bib77","doi-asserted-by":"crossref","first-page":"38529","DOI":"10.1074\/jbc.M609180200","article-title":"Tec kinase Itk forms membrane clusters specifically in the vicinity of recruiting receptors","volume":"281","author":"Qi","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2021.102842_bib78","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3899\/jrheum.100259","article-title":"Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis","volume":"37","author":"Rasmussen","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.isci.2021.102842_bib79","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T\u00a0cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2021.102842_bib80","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1073\/pnas.0709659105","article-title":"Selective targeting of ITK blocks multiple steps of HIV replication","volume":"105","author":"Readinger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2021.102842_bib81","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.tp.0000284808.28353.2c","article-title":"Sirolimus versus cyclosporine therapy increases circulating regulatory T\u00a0cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury","volume":"84","author":"Ruggenenti","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.isci.2021.102842_bib82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2013.107","article-title":"Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice","volume":"49","author":"Ruutu","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.isci.2021.102842_bib83","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2016-06-715284","article-title":"Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT","volume":"128","author":"Ryan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.isci.2021.102842_bib84","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"10.1016\/j.isci.2021.102842_bib85","doi-asserted-by":"crossref","first-page":"E966","DOI":"10.1073\/pnas.1500712112","article-title":"Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK","volume":"112","author":"Sagiv-Barfi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2021.102842_bib86","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ni734","article-title":"Mutation of Tec family kinases alters T helper cell differentiation","volume":"2","author":"Schaeffer","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2021.102842_bib88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T\u00a0cells in psoriasis: mechanism underlying unrestrained pathogenic effector T\u00a0cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib89","doi-asserted-by":"crossref","first-page":"ra122","DOI":"10.1126\/scisignal.aab0949","article-title":"Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response","volume":"8","author":"Sun","year":"2015","journal-title":"Sci. Signal"},{"key":"10.1016\/j.isci.2021.102842_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri.2016.36","article-title":"Development and maintenance of intestinal regulatory T\u00a0cells","volume":"16","author":"Tanoue","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib91","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1074\/jbc.M114.572099","article-title":"The accessory factor Nef links HIV-1 to Tec\/Btk kinases in an Src homology 3 domain-dependent manner","volume":"289","author":"Tarafdar","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2021.102842_bib92","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2021.102842_bib93","series-title":"Pneumocystis Jirovecii Pneumonia","author":"Truong","year":"2021"},{"key":"10.1016\/j.isci.2021.102842_bib94","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1097\/MIB.0b013e3182a85709","article-title":"Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T\u00a0cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T\u00a0cells in inflammatory bowel disease patients","volume":"19","author":"Ueno","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2021.102842_bib95","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/jiy552","article-title":"The potent ITK\/BTK inhibitor ibrutinib is effective for the treatment of experimental visceral leishmaniasis Caused by Leishmania donovani","volume":"219","author":"Varikuti","year":"2019","journal-title":"J.\u00a0Infect Dis."},{"key":"10.1016\/j.isci.2021.102842_bib96","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.isci.2021.102842_bib97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T\u00a0cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0625.2010.01198.x","article-title":"Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases","volume":"20","author":"von Bonin","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.isci.2021.102842_bib99","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2021.102842_bib100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/cmi.2015.89","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2021.102842_bib101","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-16-1996","article-title":"T-cell receptor signaling activates an ITK\/NF-\u03baB\/GATA-3 axis in T-cell lymphomas facilitating resistance to chemotherapy","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2021.102842_bib102","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2019-215533","article-title":"Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren's syndrome highlight T\u00a0cell-initiated autoimmunity","volume":"79","author":"Wang","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2021.102842_bib103","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2011.12.004","article-title":"Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients","volume":"244","author":"Wen","year":"2012","journal-title":"J.\u00a0Neuroimmunol"},{"key":"10.1016\/j.isci.2021.102842_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cca.2016.10.010","article-title":"Interleukin-2-inducible T-cell kinase expression and relation to disease severity in systemic lupus erythematosus","volume":"463","author":"Xu","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2021.102842_bib105","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/cid\/ciy942","article-title":"Inherited interleukin 2-inducible T-cell (ITK) kinase deficiency in siblings with epidermodysplasia verruciformis and Hodgkin lymphoma","volume":"68","author":"Youssefian","year":"2019","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.isci.2021.102842_bib106","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fphar.2019.00624","article-title":"Saikosaponin A inhibits breast cancer by regulating Th1\/Th2 balance","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.isci.2021.102842_bib107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2010.10.002","article-title":"Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis","volume":"138","author":"Zizzo","year":"2011","journal-title":"Clin. Immunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221008105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221008105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:48:52Z","timestamp":1778899732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004221008105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":108,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2589004221008105"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2021.102842","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ITK signaling for T\u00a0cell-mediated diseases","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2021.102842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"102842"}}